FDA Inspection
Par Formulations Private LimitedPar Formulations Private Limited – FDA Inspection, Jun 21, 2019
Record Details
This FDA Inspection record concerns Par Formulations Private Limited, with an inspection on June 21, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 319654a7-64af-45fd-8db5-1d83c3aca752
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1098295
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Par Formulations Private Limited
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 10, 2026 | Not classified | Office of Inspections and Investigations | |
| March 24, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 7, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 17, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 17, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Par Formulations Private Limited
- FDA Inspection 1321302 - 2026-06-10
- FDA Inspection 1205764 - 2023-03-24
- FDA Inspection 1000693 - 2016-12-07
- FDA Inspection 927362 - 2015-04-17
- FDA Inspection 855562 - 2013-10-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.